Exceptional responses to systemic treatment in metastatic breast cancer: clinical features and long-term outcomes
mBC patients achieving exceptional responses exhibit favorable long-term survival outcomes, particularly if achieving CR/NED. These findings highlight the importance of further research to refine management strategies and explore the potential for systemic treatment discontinuation in these patients.
Authors
- Davide Massa (ORCID: https://orcid.org/0000-0002-1390-4055)
- Eleonora Mioranza
- Federica Miglietta (ORCID: https://orcid.org/0000-0001-6203-874X)
- Valentina Guarneri (ORCID: https://orcid.org/0000-0002-2375-8397)
- Tommaso Giarratano (ORCID: https://orcid.org/0000-0002-6746-8877)
- Giovanni Faggioni (ORCID: https://orcid.org/0000-0002-6849-3804)
- Michele Bottosso (ORCID: https://orcid.org/0000-0002-8098-1819)
- Maria Vittoria Dieci (ORCID: https://orcid.org/0000-0002-3967-9861)
- Giorgio Bonomi
- Gaia Griguolo (ORCID: https://orcid.org/0000-0002-8782-4509)
- Davide Napetti
- A Crema
Institutions
- University of Padua (IT)
- Istituto Oncologico Veneto (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- European Journal of Cancer
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1016/j.ejca.2025.115321
- Citations
- 4
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 4.18
Funders
- Ministero della Salute
- Università degli Studi di Padova
- Associazione Italiana per la Ricerca sul Cancro
- Istituto Oncologico Veneto